Zomedica Corp. financial data

Symbol
ZOM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Phoenix Drive, Suite 125, Ann Arbor, MI
State of incorporation
Alberta, Canada
Fiscal year end
December 31
Former names
Zomedica Pharmaceuticals Corp. (to 9/28/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.25K % -25.9%
Quick Ratio 61.5 % +64%
Debt-to-equity 5.34 % -1.66%
Return On Equity -11.8 % -61%
Return On Assets -11.2 % -61.2%
Operating Margin -451 % -289%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 980M shares 0%
Common Stock, Shares, Outstanding 980M shares 0%
Entity Public Float 193M USD -9.27%
Common Stock, Value, Issued 381M USD 0%
Weighted Average Number of Shares Outstanding, Basic 980M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 980M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.37M USD -71.6%
Cost of Revenue 1.94M USD -71.6%
Research and Development Expense 2.42M USD -34.4%
Selling and Marketing Expense 3.92M USD +27.3%
General and Administrative Expense 7.98M USD +16.4%
Operating Income (Loss) -28.7M USD -10.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28.1M USD -33.6%
Income Tax Expense (Benefit) -232K USD +85.3%
Net Income (Loss) Attributable to Parent -27.8M USD -43.2%
Earnings Per Share, Basic -0.02 USD/shares 0%
Earnings Per Share, Diluted -0.05 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.94M USD -71.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.38M USD +111%
Inventory, Net 5.51M USD +51.5%
Assets, Current 89.2M USD -36.1%
Property, Plant and Equipment, Net 25M USD +243%
Operating Lease, Right-of-Use Asset 2.04M USD +50.7%
Intangible Assets, Net (Excluding Goodwill) 53.2M USD +10.7%
Goodwill 45.6M USD -28.8%
Other Assets, Noncurrent 1.19M USD +347%
Assets 220M USD -20%
Accounts Payable, Current 2.32M USD
Employee-related Liabilities, Current 2.53M USD
Accrued Liabilities, Current 4.37M USD
Contract with Customer, Liability, Current 271K USD +6.28%
Liabilities, Current 7.84M USD +8.67%
Contract with Customer, Liability, Noncurrent 282K USD -3.09%
Deferred Income Tax Liabilities, Net 759K USD -39%
Operating Lease, Liability, Noncurrent 1.55M USD +98.7%
Other Liabilities, Noncurrent 736K USD -66.3%
Liabilities 11.2M USD -27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -64K USD +89.5%
Retained Earnings (Accumulated Deficit) -204M USD -37.8%
Stockholders' Equity Attributable to Parent 209M USD -19.6%
Liabilities and Equity 220M USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.59M USD -78.3%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 5.63M USD
Common Stock, Shares, Issued 980M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.68M USD -101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.94M USD -71.6%
Deferred Tax Assets, Valuation Allowance 23.4M USD +23.4%
Deferred Tax Assets, Gross 30.4M USD +23.8%
Operating Lease, Liability 2.73M USD +57.1%
Depreciation 351K USD +99.4%
Payments to Acquire Property, Plant, and Equipment 2.34M USD +141%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -27.9M USD -39.1%
Lessee, Operating Lease, Liability, to be Paid 3.11M USD +66.8%
Property, Plant and Equipment, Gross 27.6M USD +210%
Operating Lease, Liability, Current 740K USD +15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 632K USD -6.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.07M USD +51.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +44.4%
Deferred Income Tax Expense (Benefit) -184K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 377K USD +202%
Lessee, Operating Lease, Liability, to be Paid, Year Three 603K USD +154%
Unrecognized Tax Benefits 265K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 569K USD +189%
Operating Lease, Payments 1.07M USD +152%
Amortization of Intangible Assets 1.63M USD +25.8%
Share-based Payment Arrangement, Expense 4.73M USD -30.9%
Interest Expense 50K USD